(R)-N-(2-((1-benzylpyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide, 98%, 250mg

1-(Cyclopropylmethyl)-1H-pyrazol-3-amine, 5g

1-(3-Chloropropyl)pyrrolidine, 95.0%, 25g

4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane>95.0%(GC)5g

2-Fluoro-6-methylbenzonitrile, 97.0%, 10g

8-oxo-8-(3-phenoxyphenyl)octanoic acid, 97.0%, 2g

(4-(Cyclohexyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

1,3-Bis(4-bromophenyl)-1H-pyrazol-5-ylamine, 99.0%, 100mg

N*1*-Isopropyl-N*1*-(4-methyl-benzyl)-ethane-1,2-diamine, 100mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 95+%, 1g

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 5g

(S)-7-Hydroxy-2-(4-hydroxyphenyl)chroman-4-one, 95.0%, 100mg

3-Methylpicolinic acid hydrochloride, 95.0%, 5g